GlassScriptPhysician profile
Miral Amin
NPI 1699943720
$1,604.78
in general payments reported to CMS, 2019-2025
23 companies · $73.40 in 2025
The $73.40 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $854 · 2020: $228 · 2021: $112 · 2022: $136 · 2023: $66.48 · 2024: $136 · 2025: $73.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266 · Travel and Lodging: $9.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.83 |
| Travel and Lodging | $9.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $224.02 | 2019-2020 | |
| Carl Zeiss Meditec, INC. | $197.60 | 2019 | |
| Amgen INC. | $188.33 | 2019-2020 | |
| Endomagnetics LTD | $135.91 | 2024 | Magseed, Magtrace |
| Pfizer INC. | $105.22 | 2019-2021 | |
| Medtronic, INC. | $99.03 | 2021-2022 | |
| Daiichi Sankyo INC. | $78.10 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $66.48 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $63.42 | 2019-2022 | |
| Boston Scientific Corporation | $46.73 | 2025 | Clinical Trial Product |
| Eisai INC. | $44.70 | 2019 | |
| Janssen Biotech, INC. | $40.84 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $38.83 | 2021 | |
| Allergan, INC. | $38.05 | 2019-2021 | |
| Genentech USA, INC. | $36.01 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leica Microsystems INC. | $35.75 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $35.23 | 2019-2020 | |
| Astellas Pharma US INC | $33.21 | 2020 | |
| Stryker Corporation | $26.67 | 2025 | Spy-Phi System |
| Celgene Corporation | $22.64 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $20.00 | 2019 | |
| Taiho Oncology, INC. | $15.80 | 2019 | |
| Puma Biotechnology, INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miral Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.